Randomized, placebo‐controlled, double‐blind trial with interferon‐α with and without amantadine sulphate in primary interferon‐α nonresponders with chronic hepatitis C

In primary interferon‐α (IFN‐α) nonresponders with chronic hepatitis C, retreatment with IFN‐α has only limited efficacy with sustained response rates below 10%. Therefore, the aims of the present study were to compare the efficacy and safety of IFN‐α alone or in combination with amantadine sulphate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Viral Hepat
Main Authors: Teuber, G., Berg, T., Naumann, U., Raedle, J., Brinkmann, S., Hopf, U., Zeuzem, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Ltd 2001
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7166378/
https://ncbi.nlm.nih.gov/pubmed/11454179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2893.2001.00297.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados